Updated on 5 August 2026
Drug Metabolism & Pharmacokinetics (DMPK)
Discovery Services Consultant at Sygnature Discovery
Nottingham, United Kingdom
About
Robust DMPK data is essential to every stage of drug discovery. We integrate advanced assays, predictive modelling, and translational strategies to ensure your program moves forward with confidence.
Our experts guide project teams, helping you anticipate challenges and act quickly to maximize scientific impact.
Formulation challenges such as poor solubility or polymorphic transitions can derail early discovery. We address these proactively, improving PK reliability and reducing viable candidates. Species-specific formulations enhance preclinical relevance, and early collaboration between DMPK and formulation scientists delivers measurable benefits in candidate selection and downstream development.
-
Physiochemical Profiling
-
Chemical & Metabolic Stability
-
Permeability
-
Tissue Binding
-
Drug-Drug interactions
-
Biotransformation
-
Analytical Method Development & Bioanalysis
-
In vivo Pharmacokinetic & Pharmacodynamic Studies
-
PK & PK/PD Modelling and Simulation
-
DMPK Consultancy
Type
- Research & Development
Similar opportunities
Service
- Research & Development
Gaetano Cuciniello
Discovery Services Consultant at Sygnature Discovery
Nottingham, United Kingdom
Service
Computer Aided Drug Design (CADD)
- Research & Development
Gaetano Cuciniello
Discovery Services Consultant at Sygnature Discovery
Nottingham, United Kingdom
Partnership
NIFT- First in class NEDD4 Inhibitors For cancer Therapy
- Other
- Joint development
- Technology transfer
Alessia Romussi
Intellectual Property Manager at IFOM ETS - the AIRC Institute of Molecular Oncology
Milano, Italy